Uncover key drivers, emerging technologies, and competitive movements shaping the breast cancer gene (brca) mutations treatment market from 2025–2034 with trusted insights from The Business Research Company

What Are The Market Size Estimates For The Breast Cancer Gene (BRCA) Mutations Treatment Market?

The market for treating breast cancer gene (BRCA) mutations has shown significant growth in recent years. This market is projected to expand from $4.67 billion in 2024 to $5.01 billion by 2025, exhibiting a compound annual growth rate (CAGR) of 7.4%. Historically, this expansion has been driven by factors such as the increasing availability of genetic testing, augmented government and private investment in oncology research, a heightened demand for personalized medicine, the wider adoption of preventive healthcare strategies, and a rise in the number of at-risk individuals undergoing screening.

The breast cancer gene (BRCA) mutations treatment market size is projected to experience substantial growth in the upcoming years, expanding to $6.56 billion by 2029 at a compound annual growth rate (CAGR) of 7.0%. This anticipated growth is driven by increasing inclusion of genetic testing in insurance coverage, a growing demand for companion diagnostics, a rising focus on hereditary cancer screening programs, an increase in clinical trials targeting BRCA-related cancers, and the rising adoption of risk-reducing surgical procedures. Major trends expected during this period include advancements in gene editing technologies, innovations in non-invasive diagnostic techniques, the integration of AI and machine learning in genetic risk assessment, progress in liquid biopsy applications for BRCA-related cancers, and new developments in personalized treatment algorithms.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27231&type=smp

Which Industry Forces Are Driving The Breast Cancer Gene (BRCA) Mutations Treatment Market Forward?

The breast cancer gene (BRCA) mutation treatment market is anticipated to expand due to the escalating need for targeted therapies. These medical interventions specifically attack cancer cells by focusing on genetic mutations or proteins that fuel cancer development. The heightened demand for targeted therapies primarily stems from their capacity to precisely attack disease-causing cells or molecules, thereby reducing harm to healthy tissues, which leads to greater treatment efficacy and fewer adverse effects compared to conventional treatments. For breast cancer gene (BRCA) mutations, targeted therapies are beneficial as they provide precision medicines that directly tackle the genetic changes responsible for the illness, thereby enhancing treatment results and lessening unwanted side effects. An example of this trend is seen in data from July 2023: a report from the American Society of Gene & Cell Therapy (ASGCT), a professional US-based organization, indicated that there were 247 gene therapies in Phase II at the close of Q1 2023. This figure subsequently climbed by 5%, reaching 260 by the end of Q2 2023. Consequently, the growing need for targeted therapies is propelling the expansion of the breast cancer gene (BRCA) mutation treatment market.

How Is The Breast Cancer Gene (BRCA) Mutations Treatment Market Organized By Different Segments?

The breast cancer gene (BRCA) mutations treatment market covered in this report is segmented

1) By Treatment Type: Targeted Therapies, Chemotherapy, Hormonal Therapy, Immunotherapy

2) By Indication: Breast Cancer, Ovarian Cancer, Pancreatic Cancer, Prostate Cancer

3) By Administration Route: Oral, Intravenous, Subcutaneous

4) By End-User: Hospitals, Clinics, Cancer Specialty Clinics

Subsegments:

1) By Targeted Therapies: Poly (ADP-Ribose) Polymerase Inhibitors, Mammalian Target Of Rapamycin Inhibitors, Cyclin-Dependent Kinase 4 And 6 Inhibitors, Tyrosine Kinase Inhibitors

2) By Chemotherapy: Platinum-Based chemotherapy, Anthracyclines, Taxanes, Antimetabolites

3) By Hormonal Therapy: Selective Estrogen Receptor Modulators (SERMs), Aromatase Inhibitors, Selective Estrogen Receptor Degraders (SERDs), Luteinizing Hormone-Releasing Hormone (LHRH) Agonists

4) By Immunotherapy: Immune Checkpoint Inhibitors, Cancer Vaccines, Monoclonal Antibodies, Adoptive Cell Transfer (ACT)

What Current And Upcoming Trends Are Shaping The Breast Cancer Gene (BRCA) Mutations Treatment Market?

Leading companies in the breast cancer gene (BRCA) mutation treatment market are concentrating on developing advanced solutions, such as adjuvant treatment, to improve therapeutic and patient outcomes. Adjuvant treatment is a supplementary therapy given after the primary treatment to eliminate any remaining cancer cells and reduce the likelihood of recurrence, thereby helping to enhance overall treatment success and extend patient survival. For instance, in August 2022, AstraZeneca plc, a UK-based biotechnology company, and Merck & Co., Inc., a US-based pharmaceutical company, launched LYNPARZA (olaparib). This product received European Commission approval for adult patients with germline BRCA-mutated, HER2-negative high-risk early breast cancer. This authorization allows LYNPARZA to be administered as monotherapy or in conjunction with endocrine therapy for patients who have previously undergone neoadjuvant or adjuvant chemotherapy. The approval stemmed from results of the phase 3 OlympiA trial, which demonstrated a significant improvement in invasive disease-free survival and overall survival, substantially decreasing the risk of breast cancer recurrence or death.

Who Are The Primary Market Leaders In The Breast Cancer Gene (BRCA) Mutations Treatment Market?

Major companies operating in the breast cancer gene (BRCA) mutations treatment market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Thermo Fisher Scientific Inc., AstraZeneca PLC, Novartis AG, GSK plc, Janssen Biotech Inc., Astellas Pharma Inc., Agilent Technologies Inc., Genentech Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Invitae Corporation, Guardant Health Inc., Clovis Oncology Inc., Owkin Inc., Allarity Therapeutics Inc., VBL Therapeutics.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/breast-cancer-gene-brca-mutations-treatment-global-market-report

How Do Regional Dynamics Influence The Breast Cancer Gene (BRCA) Mutations Treatment Market Performance?

North America was the largest region in the breast cancer gene (BRCA) mutations treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the breast cancer gene (BRCA) mutations treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=27231&type=smp

Browse Through More Reports Similar to the Global Breast Cancer Gene (BRCA) Mutations Treatment Market 2025, By The Business Research Company

Converted Paper Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/converted-paper-products-global-market-report

Concrete Materials Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/concrete-materials-global-market-report

Cement And Concrete Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cement-and-concrete-products-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model